Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
27
ACB Quote, Financials, Valuation and Earnings
Last price:
$3.78
Seasonality move
:
-9.8%
Day range:
$3.55 - $3.77
52-week range:
$3.28 - $6.67
Dividend yield:
0%
P/E ratio:
103.35x
P/S ratio:
0.79x
P/B ratio:
0.54x
Volume:
681.6K
Avg. volume:
1.1M
1-year change:
-35.23%
Market cap:
$212.7M
Revenue:
$246.8M
EPS (TTM):
-$1.13
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ACB
Aurora Cannabis, Inc.
|
$67.5M | -$0.02 | 71.36% | -92.1% | $6.34 |
|
ACHV
Achieve Life Sciences, Inc.
|
-- | -$0.28 | -- | -22.76% | $15.38 |
|
CEOS
CeCors, Inc.
|
-- | -- | -- | -- | -- |
|
HRAL
Hear AtLast Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
TLRY
Tilray Brands, Inc.
|
$211.1M | -- | 8.44% | -100% | $11.83 |
|
VERO
Venus Concept, Inc.
|
$14.5M | -$0.92 | -3.5% | -54.23% | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ACB
Aurora Cannabis, Inc.
|
$3.75 | $6.34 | $212.7M | 103.35x | $0.00 | 0% | 0.79x |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.37 | $15.38 | $232.6M | -- | $0.00 | 0% | -- |
|
CEOS
CeCors, Inc.
|
$0.0027 | -- | $882.7K | -- | $0.00 | 0% | 0.37x |
|
HRAL
Hear AtLast Holdings, Inc.
|
$0.0004 | -- | $203.5K | -- | $0.00 | 0% | -- |
|
TLRY
Tilray Brands, Inc.
|
$7.89 | $11.83 | $915.2M | -- | $0.00 | 0% | 0.95x |
|
VERO
Venus Concept, Inc.
|
$0.37 | -- | $687.9K | -- | $0.00 | 0% | 0.01x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ACB
Aurora Cannabis, Inc.
|
15.85% | 0.185 | 28.09% | 1.36x |
|
ACHV
Achieve Life Sciences, Inc.
|
22.85% | 2.418 | 5.99% | 4.94x |
|
CEOS
CeCors, Inc.
|
-- | -2.760 | -- | -- |
|
HRAL
Hear AtLast Holdings, Inc.
|
-774.23% | 1.085 | -- | 0.00x |
|
TLRY
Tilray Brands, Inc.
|
16.83% | 3.038 | 35.13% | 1.54x |
|
VERO
Venus Concept, Inc.
|
92.44% | 1.796 | 689.6% | 0.48x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ACB
Aurora Cannabis, Inc.
|
$4M | -$26M | -14.03% | -16.46% | -38.47% | $8.3M |
|
ACHV
Achieve Life Sciences, Inc.
|
-$54K | -$14.7M | -139.57% | -189.88% | -- | -$11.3M |
|
CEOS
CeCors, Inc.
|
-- | -- | -- | -- | -- | -- |
|
HRAL
Hear AtLast Holdings, Inc.
|
-- | -$51K | -- | -- | -- | -$21.3K |
|
TLRY
Tilray Brands, Inc.
|
$53.1M | -$20M | -84.8% | -98.18% | -9.2% | -$18M |
|
VERO
Venus Concept, Inc.
|
$8.8M | -$9.5M | -129.08% | -1236.95% | -68.93% | -$4.9M |
Aurora Cannabis, Inc. vs. Competitors
-
Which has Higher Returns ACB or ACHV?
Achieve Life Sciences, Inc. has a net margin of -1.85% compared to Aurora Cannabis, Inc.'s net margin of --. Aurora Cannabis, Inc.'s return on equity of -16.46% beat Achieve Life Sciences, Inc.'s return on equity of -189.88%.
Company Gross Margin Earnings Per Share Invested Capital ACBAurora Cannabis, Inc.5.93% $0.02 $487.9M ACHVAchieve Life Sciences, Inc.-- -$0.28 $43.6M -
What do Analysts Say About ACB or ACHV?
Aurora Cannabis, Inc. has a consensus price target of $6.34, signalling upside risk potential of 68.95%. On the other hand Achieve Life Sciences, Inc. has an analysts' consensus of $15.38 which suggests that it could grow by 251.83%. Given that Achieve Life Sciences, Inc. has higher upside potential than Aurora Cannabis, Inc., analysts believe Achieve Life Sciences, Inc. is more attractive than Aurora Cannabis, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ACBAurora Cannabis, Inc.3 2 0 ACHVAchieve Life Sciences, Inc.5 0 0 -
Is ACB or ACHV More Risky?
Aurora Cannabis, Inc. has a beta of 0.387, which suggesting that the stock is 61.336% less volatile than S&P 500. In comparison Achieve Life Sciences, Inc. has a beta of 1.819, suggesting its more volatile than the S&P 500 by 81.923%.
-
Which is a Better Dividend Stock ACB or ACHV?
Aurora Cannabis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Achieve Life Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Cannabis, Inc. pays -- of its earnings as a dividend. Achieve Life Sciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ACB or ACHV?
Aurora Cannabis, Inc. quarterly revenues are $67.6M, which are larger than Achieve Life Sciences, Inc. quarterly revenues of --. Aurora Cannabis, Inc.'s net income of -$1.3M is higher than Achieve Life Sciences, Inc.'s net income of -$14.4M. Notably, Aurora Cannabis, Inc.'s price-to-earnings ratio is 103.35x while Achieve Life Sciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Cannabis, Inc. is 0.79x versus -- for Achieve Life Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ACBAurora Cannabis, Inc.0.79x 103.35x $67.6M -$1.3M ACHVAchieve Life Sciences, Inc.-- -- -- -$14.4M
-
Which has Higher Returns ACB or CEOS?
CeCors, Inc. has a net margin of -1.85% compared to Aurora Cannabis, Inc.'s net margin of --. Aurora Cannabis, Inc.'s return on equity of -16.46% beat CeCors, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ACBAurora Cannabis, Inc.5.93% $0.02 $487.9M CEOSCeCors, Inc.-- -- -- -
What do Analysts Say About ACB or CEOS?
Aurora Cannabis, Inc. has a consensus price target of $6.34, signalling upside risk potential of 68.95%. On the other hand CeCors, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aurora Cannabis, Inc. has higher upside potential than CeCors, Inc., analysts believe Aurora Cannabis, Inc. is more attractive than CeCors, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ACBAurora Cannabis, Inc.3 2 0 CEOSCeCors, Inc.0 0 0 -
Is ACB or CEOS More Risky?
Aurora Cannabis, Inc. has a beta of 0.387, which suggesting that the stock is 61.336% less volatile than S&P 500. In comparison CeCors, Inc. has a beta of 0.723, suggesting its less volatile than the S&P 500 by 27.734%.
-
Which is a Better Dividend Stock ACB or CEOS?
Aurora Cannabis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CeCors, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Cannabis, Inc. pays -- of its earnings as a dividend. CeCors, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ACB or CEOS?
Aurora Cannabis, Inc. quarterly revenues are $67.6M, which are larger than CeCors, Inc. quarterly revenues of --. Aurora Cannabis, Inc.'s net income of -$1.3M is higher than CeCors, Inc.'s net income of --. Notably, Aurora Cannabis, Inc.'s price-to-earnings ratio is 103.35x while CeCors, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Cannabis, Inc. is 0.79x versus 0.37x for CeCors, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ACBAurora Cannabis, Inc.0.79x 103.35x $67.6M -$1.3M CEOSCeCors, Inc.0.37x -- -- --
-
Which has Higher Returns ACB or HRAL?
Hear AtLast Holdings, Inc. has a net margin of -1.85% compared to Aurora Cannabis, Inc.'s net margin of --. Aurora Cannabis, Inc.'s return on equity of -16.46% beat Hear AtLast Holdings, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ACBAurora Cannabis, Inc.5.93% $0.02 $487.9M HRALHear AtLast Holdings, Inc.-- -- -$362.8K -
What do Analysts Say About ACB or HRAL?
Aurora Cannabis, Inc. has a consensus price target of $6.34, signalling upside risk potential of 68.95%. On the other hand Hear AtLast Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aurora Cannabis, Inc. has higher upside potential than Hear AtLast Holdings, Inc., analysts believe Aurora Cannabis, Inc. is more attractive than Hear AtLast Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ACBAurora Cannabis, Inc.3 2 0 HRALHear AtLast Holdings, Inc.0 0 0 -
Is ACB or HRAL More Risky?
Aurora Cannabis, Inc. has a beta of 0.387, which suggesting that the stock is 61.336% less volatile than S&P 500. In comparison Hear AtLast Holdings, Inc. has a beta of 0.388, suggesting its less volatile than the S&P 500 by 61.2%.
-
Which is a Better Dividend Stock ACB or HRAL?
Aurora Cannabis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hear AtLast Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Cannabis, Inc. pays -- of its earnings as a dividend. Hear AtLast Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ACB or HRAL?
Aurora Cannabis, Inc. quarterly revenues are $67.6M, which are larger than Hear AtLast Holdings, Inc. quarterly revenues of --. Aurora Cannabis, Inc.'s net income of -$1.3M is lower than Hear AtLast Holdings, Inc.'s net income of -$152.6K. Notably, Aurora Cannabis, Inc.'s price-to-earnings ratio is 103.35x while Hear AtLast Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Cannabis, Inc. is 0.79x versus -- for Hear AtLast Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ACBAurora Cannabis, Inc.0.79x 103.35x $67.6M -$1.3M HRALHear AtLast Holdings, Inc.-- -- -- -$152.6K
-
Which has Higher Returns ACB or TLRY?
Tilray Brands, Inc. has a net margin of -1.85% compared to Aurora Cannabis, Inc.'s net margin of -20%. Aurora Cannabis, Inc.'s return on equity of -16.46% beat Tilray Brands, Inc.'s return on equity of -98.18%.
Company Gross Margin Earnings Per Share Invested Capital ACBAurora Cannabis, Inc.5.93% $0.02 $487.9M TLRYTilray Brands, Inc.24.43% -$0.41 $1.9B -
What do Analysts Say About ACB or TLRY?
Aurora Cannabis, Inc. has a consensus price target of $6.34, signalling upside risk potential of 68.95%. On the other hand Tilray Brands, Inc. has an analysts' consensus of $11.83 which suggests that it could grow by 49.87%. Given that Aurora Cannabis, Inc. has higher upside potential than Tilray Brands, Inc., analysts believe Aurora Cannabis, Inc. is more attractive than Tilray Brands, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ACBAurora Cannabis, Inc.3 2 0 TLRYTilray Brands, Inc.2 7 0 -
Is ACB or TLRY More Risky?
Aurora Cannabis, Inc. has a beta of 0.387, which suggesting that the stock is 61.336% less volatile than S&P 500. In comparison Tilray Brands, Inc. has a beta of 2.022, suggesting its more volatile than the S&P 500 by 102.181%.
-
Which is a Better Dividend Stock ACB or TLRY?
Aurora Cannabis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tilray Brands, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Cannabis, Inc. pays -- of its earnings as a dividend. Tilray Brands, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ACB or TLRY?
Aurora Cannabis, Inc. quarterly revenues are $67.6M, which are smaller than Tilray Brands, Inc. quarterly revenues of $217.5M. Aurora Cannabis, Inc.'s net income of -$1.3M is higher than Tilray Brands, Inc.'s net income of -$43.5M. Notably, Aurora Cannabis, Inc.'s price-to-earnings ratio is 103.35x while Tilray Brands, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Cannabis, Inc. is 0.79x versus 0.95x for Tilray Brands, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ACBAurora Cannabis, Inc.0.79x 103.35x $67.6M -$1.3M TLRYTilray Brands, Inc.0.95x -- $217.5M -$43.5M
-
Which has Higher Returns ACB or VERO?
Venus Concept, Inc. has a net margin of -1.85% compared to Aurora Cannabis, Inc.'s net margin of -163.68%. Aurora Cannabis, Inc.'s return on equity of -16.46% beat Venus Concept, Inc.'s return on equity of -1236.95%.
Company Gross Margin Earnings Per Share Invested Capital ACBAurora Cannabis, Inc.5.93% $0.02 $487.9M VEROVenus Concept, Inc.64% -$12.14 $35.8M -
What do Analysts Say About ACB or VERO?
Aurora Cannabis, Inc. has a consensus price target of $6.34, signalling upside risk potential of 68.95%. On the other hand Venus Concept, Inc. has an analysts' consensus of -- which suggests that it could grow by 31413.51%. Given that Venus Concept, Inc. has higher upside potential than Aurora Cannabis, Inc., analysts believe Venus Concept, Inc. is more attractive than Aurora Cannabis, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ACBAurora Cannabis, Inc.3 2 0 VEROVenus Concept, Inc.0 1 0 -
Is ACB or VERO More Risky?
Aurora Cannabis, Inc. has a beta of 0.387, which suggesting that the stock is 61.336% less volatile than S&P 500. In comparison Venus Concept, Inc. has a beta of -0.011, suggesting its less volatile than the S&P 500 by 101.098%.
-
Which is a Better Dividend Stock ACB or VERO?
Aurora Cannabis, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Venus Concept, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Cannabis, Inc. pays -- of its earnings as a dividend. Venus Concept, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ACB or VERO?
Aurora Cannabis, Inc. quarterly revenues are $67.6M, which are larger than Venus Concept, Inc. quarterly revenues of $13.8M. Aurora Cannabis, Inc.'s net income of -$1.3M is higher than Venus Concept, Inc.'s net income of -$22.5M. Notably, Aurora Cannabis, Inc.'s price-to-earnings ratio is 103.35x while Venus Concept, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Cannabis, Inc. is 0.79x versus 0.01x for Venus Concept, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ACBAurora Cannabis, Inc.0.79x 103.35x $67.6M -$1.3M VEROVenus Concept, Inc.0.01x -- $13.8M -$22.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
23
CAR alert for Feb 20
Avis Budget Group, Inc. [CAR] is down 0.3% over the past day.
Buy
75
HYMC alert for Feb 20
Hycroft Mining Holding Corp. [HYMC] is down 2.47% over the past day.
Sell
1
EPAM alert for Feb 20
EPAM Systems, Inc. [EPAM] is down 0.11% over the past day.
